Sakhuja, R; Kondabolu, K; Córdova-Sintjago, T; Travers, S; Vincek, AS; Kim, MS; Abboud, KA; Fang, L; Sun, Z; Canal, CE; Booth, RG. Novel 4-substituted-N,N-dimethyltetrahydronaphthalen-2-amines: Synthesis, affinity, and in silico docking studies at serotonin 5-HT2-type and histamine H1 G protein-coupled receptors. Bioorg. Med. Chem., 1 Apr 2015, 23 (7), 1588–1600. 951 kB. https://doi.org/10.1016/j.bmc.2015.01.060 #PAT
Canal, CE; Morgan, D; Felsing, D; Kondabolu, K; Rowland, NE; Robertson, KL; Sakhuja, R; Booth, RG. A novel aminotetralin-type serotonin (5-HT) 2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses. J. Pharmacol. Exp. Ther., 1 May 2014, 349 (2), 310–318. 981 kB. https://doi.org/10.1124/jpet.113.212373 #PAT
Canal, CE; Booth, RG; Morgan, D. Support for 5-HT2C receptor functional selectivity in vivo utilizing structurally diverse, selective 5-HT2C receptor ligands and the 2,5-dimethoxy-4-iodoamphetamine elicited head-twitch response model. Neuropharmacology, 1 Jul 2013, 70, 112–121. 1.1 MB. https://doi.org/10.1016/j.neuropharm.2013.01.007 #PAT